In colorectal cancer mice with liver metastasis, blockade of TGF-β signaling, which is an important factor in the microenvironment in liver metastasis, has been found to rendered tumors susceptible to anti-PD-1 therapy (14–17). This evidence concerns the gene PDCD1 and colorectal cancer.